Is Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools?

Greenhaven Road Capital's Q3 2024 investor letter highlighted Cellebrite DI Ltd. (NASDAQ:CLBT), a software company that develops solutions for investigations. The stock had a one-month return of -1.05% and a 124.